These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 38641340)

  • 41. The value of sensory nerve conduction studies in the diagnosis of Guillain-Barré syndrome.
    Freiha J; Zoghaib R; Makhoul K; Maalouf N; Riachi N; Chalah MA; Ayache SS; Ahdab R
    Clin Neurophysiol; 2021 May; 132(5):1157-1162. PubMed ID: 33780722
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The pathogenic relevance of α
    Dong C; Palladino SP; Helton ES; Ubogu EE
    Acta Neuropathol; 2016 Nov; 132(5):739-752. PubMed ID: 27460017
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Guillain-Barré syndrome in children - High occurrence of Miller Fisher syndrome in East Asian region.
    Chiu ATG; Chan RWK; Yau MLY; Yuen ACL; Lam AKF; Lau SWY; Lau AMC; Fung STH; Ma KH; Lau CWL; Yau MM; Ko CH; Tsui KW; Ma CK; Tai SM; Yau EKC; Fung E; Wu SP; Kwong KL; Chan SHS
    Brain Dev; 2022 Nov; 44(10):715-724. PubMed ID: 35906115
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Axonal pathology in early stages of Guillain-Barré syndrome.
    Berciano J
    Neurologia (Engl Ed); 2022; 37(6):466-479. PubMed ID: 30057217
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Guillain-BarrÉ syndrome subtype diagnosis: A prospective multicentric European study.
    Van den Bergh PYK; Piéret F; Woodard JL; Attarian S; Grapperon AM; Nicolas G; Brisset M; Cassereau J; Rajabally YA; Van Parijs V; Verougstraete D; Jacquerye P; Raymackers JM; Redant C; Michel C; Delmont E;
    Muscle Nerve; 2018 Jan; ():. PubMed ID: 29315669
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Association between hyperCKemia and axonal degeneration in Guillain-Barré syndrome.
    Lee EK; Kim S; Jo N; Sohn E
    BMC Neurol; 2023 Mar; 23(1):92. PubMed ID: 36864392
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Demyelinating Guillain-Barré syndrome recurs more frequently than axonal subtypes.
    Notturno F; Kokubun N; Sekiguki Y; Nagashima T; De Lauretis A; Yuki N; Kuwabara S; Uncini A
    J Neurol Sci; 2016 Jun; 365():132-6. PubMed ID: 27206890
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Sural nerve involvement in Guillain-Barré syndrome: Clinical and prognostic implications. A prospective cohort.
    López-Hernández JC; Rivas-Cruz MA; Galnares-Olalde JA; López-Alderete JA; López-Pizano A; Alcalá RE; Villanueva AV; Vargas-Cañas ES
    J Clin Neurosci; 2023 Apr; 110():48-52. PubMed ID: 36791495
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Subtypes and Prognosis of Guillain-Barré Syndrome in Southwest China.
    Zhang G; Li Q; Zhang R; Wei X; Wang J; Qin X
    PLoS One; 2015; 10(7):e0133520. PubMed ID: 26200903
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Electrodiagnostic criteria for Guillain-Barrè syndrome: a critical revision and the need for an update.
    Uncini A; Kuwabara S
    Clin Neurophysiol; 2012 Aug; 123(8):1487-95. PubMed ID: 22480600
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A-waves in Guillain-Barré syndrome: correlation with electrophysiological subtypes and antiganglioside antibodies.
    Kawakami S; Sonoo M; Kadoya A; Chiba A; Shimizu T
    Clin Neurophysiol; 2012 Jun; 123(6):1234-41. PubMed ID: 22055840
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A model to predict the probability of acute inflammatory demyelinating polyneuropathy.
    Tan CY; Sekiguchi Y; Goh KJ; Kuwabara S; Shahrizaila N
    Clin Neurophysiol; 2020 Jan; 131(1):63-69. PubMed ID: 31751842
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Increased incidence of axonal Guillain-Barré syndrome in La Spezia area of Italy: A 13-year follow-up study.
    Benedetti L; Briani C; Beronio A; Massa F; Giorli E; Sani C; Delia P; Artioli S; Sormani MP; Mannironi A; Tartaglione A; Mancardi GL
    J Peripher Nerv Syst; 2019 Mar; 24(1):80-86. PubMed ID: 30421471
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Differential distribution of HLA-DQ beta/DR beta epitopes in the two forms of Guillain-Barré syndrome, acute motor axonal neuropathy and acute inflammatory demyelinating polyneuropathy (AIDP): identification of DQ beta epitopes associated with susceptibility to and protection from AIDP.
    Magira EE; Papaioakim M; Nachamkin I; Asbury AK; Li CY; Ho TW; Griffin JW; McKhann GM; Monos DS
    J Immunol; 2003 Mar; 170(6):3074-80. PubMed ID: 12626563
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Optimizing electrodiagnosis for Guillain-Barré syndrome: Clues from clinical practice.
    Rajabally YA; Hiew FL
    Muscle Nerve; 2017 May; 55(5):748-751. PubMed ID: 27750406
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Recurrent Guillain-Barré Syndrome - Case Series.
    Basta I; Bozovic I; Berisavac I; Stojiljkovic-Tamas O; Rajic SL; Dominovic-Kovacevic A; Stojanov A; Djordjevic G; Jovanovic D; Peric S
    Neurol India; 2019; 67(6):1536-1538. PubMed ID: 31857555
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Early electrophysiological study variants and their relationship with clinical presentation and outcomes of patients with Guillain-Barré syndrome.
    Khedr EM; Shehab MM; Mohamed MZ; Mohamed KO
    Sci Rep; 2023 Aug; 13(1):14000. PubMed ID: 37634022
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Study of total duration of distal compound muscle action potential in demyelinating and axonal Guillain-Barre' syndrome.
    Ginanneschi F; Cioncoloni D; Capoccitti G; Volpi N; Ferretti F; Giannini F; Rossi A
    Neurol Res; 2023 Apr; 45(4):381-389. PubMed ID: 36403142
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Electrophysiological Pattern and Predictors of Functional Outcome of Patients with Guillain Barre Syndrome at a Tertiary Care Hospital in Pakistan.
    Siddiqui M; Majid S; Yusuf H; Mateen F
    J Coll Physicians Surg Pak; 2022 Mar; 32(3):364-368. PubMed ID: 35148591
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A unicenter, prospective study of Guillain-Barré syndrome in Spain.
    Sedano MJ; Orizaola P; Gallardo E; García A; Pelayo-Negro AL; Sánchez-Juan P; Infante J; Berciano J
    Acta Neurol Scand; 2019 Jun; 139(6):546-554. PubMed ID: 30929269
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.